Standard Biotools (LAB) Goodwill & Intangibles (2016 - 2025)
Standard Biotools has reported Goodwill & Intangibles over the past 12 years, most recently at $139.8 million for Q1 2025.
- Quarterly Goodwill & Intangibles rose 6.65% to $139.8 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $139.8 million through Mar 2025, up 6.65% year-over-year, with the annual reading at $140.3 million for FY2024, 30.2% up from the prior year.
- Goodwill & Intangibles was $139.8 million for Q1 2025 at Standard Biotools, roughly flat from $140.3 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $143.5 million in Q1 2021 and troughed at $107.7 million in Q4 2023.
- The 5-year median for Goodwill & Intangibles is $130.3 million (2024), against an average of $127.5 million.
- Year-over-year, Goodwill & Intangibles soared 1787.58% in 2021 and then dropped 11.61% in 2022.
- A 5-year view of Goodwill & Intangibles shows it stood at $134.3 million in 2021, then dropped by 11.51% to $118.9 million in 2022, then dropped by 9.37% to $107.7 million in 2023, then surged by 30.2% to $140.3 million in 2024, then decreased by 0.34% to $139.8 million in 2025.
- Per Business Quant, the three most recent readings for LAB's Goodwill & Intangibles are $139.8 million (Q1 2025), $140.3 million (Q4 2024), and $126.3 million (Q3 2024).